NASDAQ:RMTI Rockwell Medical Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Rockwell Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $1.28 -0.01 (-0.78%) (As of 07/1/2022 03:26 PM ET) Add Compare Share Today's Range$1.26▼$1.2950-Day Range$1.28▼$22.2252-Week Range$1.25▼$10.02Volume645 shsAverage Volume108,678 shsMarket Capitalization$12.01 millionP/E RatioN/ADividend YieldN/APrice Target$33.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Rockwell Medical MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside2,478.1% Upside$33.00 Price TargetShort InterestBearish3.49% of Float Sold ShortDividend StrengthN/ASustainability-2.35Upright™ Environmental ScoreNews Sentiment1.24Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($3.56) to ($3.92) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.1.97 out of 5 starsMedical Sector532nd out of 1,428 stocksPharmaceutical Preparations Industry252nd out of 680 stocks 3.5 Analyst's Opinion Consensus RatingRockwell Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $33.00, Rockwell Medical has a forecasted upside of 2,478.1% from its current price of $1.28.Amount of Analyst CoverageRockwell Medical has received no research coverage in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted3.49% of the float of Rockwell Medical has been sold short.Short Interest Ratio / Days to CoverRockwell Medical has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in Rockwell Medical has recently increased by 14.03%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldRockwell Medical does not currently pay a dividend.Dividend GrowthRockwell Medical does not have a long track record of dividend growth. Previous Next 3.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreRockwell Medical has received a 58.29% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Iron deficiency medication" and "Clinical research services for deficiency diseases" products. See details.Environmental SustainabilityThe Environmental Impact score for Rockwell Medical is -2.35. Previous Next 2.9 News and Social Media Coverage News SentimentRockwell Medical has a news sentiment score of 1.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.79 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Rockwell Medical this week, compared to 1 article on an average week.Search InterestOnly 3 people have searched for RMTI on MarketBeat in the last 30 days. This is a decrease of -63% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Rockwell Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Rockwell Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.90% of the stock of Rockwell Medical is held by insiders.Percentage Held by InstitutionsOnly 27.88% of the stock of Rockwell Medical is held by institutions. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Rockwell Medical are expected to decrease in the coming year, from ($3.56) to ($3.92) per share.Price to Book Value per Share RatioRockwell Medical has a P/B Ratio of 4.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive RMTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address About Rockwell Medical (NASDAQ:RMTI) StockRockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.Read More RMTI Stock News HeadlinesJune 24, 2022 | nasdaq.comRockwell Medical CEO Russell Ellison Quits; Mark Strobeck Named ReplacementJune 24, 2022 | nasdaq.comRockwell Medical CEO Russell Ellison Quits; Mark Strobeck Named ReplacementJune 23, 2022 | finance.yahoo.comRockwell Medical Receives Additional FDA Feedback On Anemia CandidateJune 23, 2022 | americanbankingnews.comRockwell Medical (NASDAQ:RMTI) Coverage Initiated by Analysts at StockNews.comJune 22, 2022 | finance.yahoo.comRockwell Medical, Inc. Appoints Mark Strobeck, Ph.D., as President and Chief Executive OfficerJune 22, 2022 | seekingalpha.comRockwell Medical drops 14% as CEO departsJune 22, 2022 | finance.yahoo.comRockwell Medical Provides Corporate and Clinical UpdateJune 14, 2022 | americanbankingnews.comStockNews.com Begins Coverage on Rockwell Medical (NASDAQ:RMTI)June 14, 2022 | americanbankingnews.comCritical Comparison: Prothena (NASDAQ:PRTA) vs. Rockwell Medical (NASDAQ:RMTI)June 9, 2022 | americanbankingnews.comRockwell Medical, Inc. to Post FY2023 Earnings of ($3.92) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:RMTI)June 7, 2022 | finance.yahoo.comRockwell Medical Closes $15 Million Financing from Leading Healthcare InvestorJune 1, 2022 | seekingalpha.comRockwell Medical regains Nasdaq minimum bid price complianceJune 1, 2022 | finance.yahoo.comRockwell Medical Regains Compliance with Nasdaq Listing RequirementsMay 31, 2022 | seekingalpha.comRockwell Medical launches $15M at-market offeringMay 31, 2022 | finance.yahoo.comRockwell Medical Announces $15 Million At-Market OfferingMay 23, 2022 | finance.yahoo.comRockwell Medical, Inc. to Present at H.C. Wainwright Annual Global Life Sciences ConferenceMay 16, 2022 | seekingalpha.comRockwell Medical, Inc. (RMTI) CEO Russell Ellison on Q1 2022 Results - Earnings Call TranscriptMay 16, 2022 | investing.comRockwell Medical Reports Q1 Loss of $0.84/shMay 16, 2022 | finance.yahoo.comRockwell Medical Provides First Quarter 2022 Financial and Operational UpdateMay 15, 2022 | seekingalpha.comRockwell Medical Q4 2021 Earnings PreviewMay 13, 2022 | finanznachrichten.deRockwell Medical Technologies, Inc.: Rockwell Medical Announces 1-for-11 Reverse Stock SplitMay 13, 2022 | benzinga.comPreview: Rockwell Medical's EarningsMay 12, 2022 | finance.yahoo.comRockwell Medical Submits Additional Data For IND Application For Iron Deficiency CandidateMay 12, 2022 | seekingalpha.comRockwell Medical stock slides on 1-for-11 reverse splitMay 12, 2022 | finance.yahoo.comRockwell Medical Announces 1-for-11 Reverse Stock SplitSee More Headlines Industry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:RMTI CUSIP77437410 CIK1041024 Webwww.rockwellmed.com Phone(248) 960-9009Fax248-960-9119Employees300Year Founded1995Company Calendar Last Earnings5/19/2022Today7/04/2022Next Earnings (Estimated)8/15/2022Fiscal Year End12/31/2022Price Target and Rating Average Stock Price Forecast$33.00 High Stock Price Forecast$33.00 Low Stock Price Forecast$33.00 Forecasted Upside/Downside+2,478.1%Consensus RatingBuy Rating Score (0-4)3 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-32,670,000.00 Net Margins-51.27% Pretax Margin-51.27% Return on Equity-474.88% Return on Assets-61.58% Debt Debt-to-Equity Ratio5.21 Current Ratio1.27 Quick Ratio0.98 Sales & Book Value Annual Sales$61.93 million Price / Sales0.19 Cash FlowN/A Price / Cash FlowN/A Book Value$0.30 per share Price / Book4.27Miscellaneous Outstanding Shares9,385,000Free Float9,113,000Market Cap$12.01 million OptionableOptionable Beta1.18 Social Links Rockwell Medical Frequently Asked Questions Should I buy or sell Rockwell Medical stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Rockwell Medical stock. View analyst ratings for Rockwell Medical or view top-rated stocks. What is Rockwell Medical's stock price forecast for 2022? 1 Wall Street analysts have issued 12 month price objectives for Rockwell Medical's stock. Their RMTI stock forecasts range from $33.00 to $33.00. On average, they anticipate Rockwell Medical's share price to reach $33.00 in the next year. This suggests a possible upside of 2,478.1% from the stock's current price. View analysts' price targets for Rockwell Medical or view top-rated stocks among Wall Street analysts. How has Rockwell Medical's stock price performed in 2022? Rockwell Medical's stock was trading at $4.51 on January 1st, 2022. Since then, RMTI stock has decreased by 71.6% and is now trading at $1.28. View the best growth stocks for 2022 here. When is Rockwell Medical's next earnings date? Rockwell Medical is scheduled to release its next quarterly earnings announcement on Monday, August 15th 2022. View our earnings forecast for Rockwell Medical. How were Rockwell Medical's earnings last quarter? Rockwell Medical, Inc. (NASDAQ:RMTI) posted its quarterly earnings data on Thursday, May, 19th. The company reported ($0.84) earnings per share for the quarter, topping analysts' consensus estimates of ($0.99) by $0.15. The business earned $16.12 million during the quarter, compared to the consensus estimate of $18.80 million. Rockwell Medical had a negative net margin of 51.27% and a negative trailing twelve-month return on equity of 474.88%. During the same period in the prior year, the firm earned ($0.08) EPS. View Rockwell Medical's earnings history. When did Rockwell Medical's stock split? How did Rockwell Medical's stock split work? Rockwell Medical shares reverse split before market open on Friday, May 13th 2022. The 1-11 reverse split was announced on Friday, May 13th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 13th 2022. An investor that had 100 shares of Rockwell Medical stock prior to the reverse split would have 9 shares after the split. Who are Rockwell Medical's key executives? Rockwell Medical's management team includes the following people: Dr. Russell H. Ellison M.D., M.Sc., MSc., Pres, CEO & Director (Age 74, Pay $501.13k)Mr. Russell L. Skibsted M.B.A., Exec. VP, CFO & Chief Bus. Officer (Age 63, Pay $598.92k)Mr. Michael DeYoung, VP of OperationsMr. Paul E. McGarry, VP, Corp. Controller & Principal Accounting Officer (Age 54)Ms. Megan C. Timmins, Sr. VP, Gen. Counsel & Corp. Sec. (Age 49)Mr. James A. McCarthy, Sr. VP of Bus. & Corp. Devel.Mr. Timothy T. Chole, Sr. VP of Sales & MarketingDr. Marc L. Hoffman, Chief Medical Officer (Age 61)Mr. David J. Kull, Sec. (Age 54)Mr. Jason Finkelstein, Investor Relations Representative What is Robert L. Chioini's approval rating as Rockwell Medical's CEO? 6 employees have rated Rockwell Medical CEO Robert L. Chioini on Glassdoor.com. Robert L. Chioini has an approval rating of 22% among Rockwell Medical's employees. This puts Robert L. Chioini in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. Who are some of Rockwell Medical's key competitors? Some companies that are related to Rockwell Medical include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), Baxter International (BAX), ResMed (RMD), DexCom (DXCM), IDEXX Laboratories (IDXX), STERIS (STE), Hologic (HOLX), Insulet (PODD) and Teleflex (TFX). View all of RMTI's competitors. What other stocks do shareholders of Rockwell Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Rockwell Medical investors own include Immunomedics (IMMU), JinkoSolar (JKS), Seagen (SGEN), Geron (GERN), OPKO Health (OPK), Amarin (AMRN), Gilead Sciences (GILD), ImmunoGen (IMGN), Sorrento Therapeutics (SRNE) and VBI Vaccines (VBIV). What is Rockwell Medical's stock symbol? Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI." How do I buy shares of Rockwell Medical? Shares of RMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Rockwell Medical's stock price today? One share of RMTI stock can currently be purchased for approximately $1.28. How much money does Rockwell Medical make? Rockwell Medical (NASDAQ:RMTI) has a market capitalization of $12.01 million and generates $61.93 million in revenue each year. How many employees does Rockwell Medical have? Rockwell Medical employs 300 workers across the globe. When was Rockwell Medical founded? Rockwell Medical was founded in 1995. How can I contact Rockwell Medical? Rockwell Medical's mailing address is 411 HACKENSACK AVENUE SUITE 501, HACKENSACK NJ, 07601. The official website for Rockwell Medical is www.rockwellmed.com. The company can be reached via phone at (248) 960-9009, via email at invest@rockwellmed.com, or via fax at 248-960-9119. This page (NASDAQ:RMTI) was last updated on 7/4/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
